Pre-eclampsia in a woman whose child suffered from lethal carnitine-acylcarnitine translocase deficiency.

BJOG: An International Journal of Obstetrics & GynaecologyVolume 114, Issue 8 p. 1028-1030 Pre-eclampsia in a woman whose child suffered from lethal carnitine-acylcarnitine translocase deficiency WB Geven, Corresponding Author WB Geven a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsDr WB Geven, Department of Pediatrics, Martini Hospital, PO Box 30033,9700 RM Groningen, the Netherlands. Email [email protected]Search for more papers by this author a KE Niezen-Koning, KE Niezen-Koning a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author b A Timmer, A Timmer a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author c AJ Van Loon, AJ Van Loon a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author d RJA Wanders, RJA Wanders a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author e FJ Van Spronsen, FJ Van Spronsen a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author f WB Geven, Corresponding Author WB Geven a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsDr WB Geven, Department of Pediatrics, Martini Hospital, PO Box 30033,9700 RM Groningen, the Netherlands. Email [email protected]Search for more papers by this author a KE Niezen-Koning, KE Niezen-Koning a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author b A Timmer, A Timmer a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author c AJ Van Loon, AJ Van Loon a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author d RJA Wanders, RJA Wanders a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author e FJ Van Spronsen, FJ Van Spronsen a Department of Pediatrics, Martini Hospital, Groningen, the Netherlands b Laboratory for Metabolic Diseases and c Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, d Department of Obstetrics, Martini Hospital, Groningen, the Netherlandse Department of Clinical Chemistry and Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlandsf Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsSearch for more papers by this author f First published: 18 June 2007 https://doi.org/10.1111/j.1471-0528.2007.01411.xCitations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Ventura FV, Costa CG, Struys EA, Ruiter J, Allers P, Ijlst L, et al. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 1999; 281: 1–17. 2 Ijlst L, Ruiter JPN, Roermund van CWT, Wanders RJA. Mitochondrial carnitine/acylcarnitine translocase deficiency. In: S Eaton, PA Quant, editors. New Avenues of Research in Fatty Acid Oxidation and Ketone Body Metabolism. London: FAOXK Press; 2001. pp. 33–7. 3 Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359–75. 4 Xiong X, Fraser WD, Demianczuk NN. History of abortion, preterm, term birth and risk of preeclampsia: a population based study. Am J Obstet Gynecol 2002; 187: 1013–18. 5 Henriksen T. The role of lipid oxidation and oxidative lipid derivatives in the development of preeclampsia. Semin Perinatol 2000; 24: 29–32. 6 Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000; 21: 597–602. 7 Oey NA, Den Boer MEJ, Ruiter JP, Wanders RJ, Duran M, Waterham HR, et al. High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis 2003; 26: 385–92. 8 Shekhawat P, Bennet MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation and maternal liver diseases. Am J Physiol Endocrinol Metab 2003; 284: E1098–105. 9 Ibdah JA, Bennet MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999; 340: 1723–31. 10 Matern D, Hart P, Murtha AP, Vockley J, Gregersen N, Millington DS, et al. Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 2001; 138: 585–8. 11 Nelson J, Lewis B, Walters B. The HELLP syndrome associated with fetal medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2000; 23: 518–19. 12 Innes AM, Seargeant LE, Balachandra K, Roe CR, Wanders RJ, Ruiter JP, et al. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res 2000; 47: 43–5. 13 Tein I. Metabolic disease in the fetus predisposes to maternal complications of pregnancy. Pediatr Res 2000; 47: 6–8. 14 Rubio-Gozalbo ME, Vos P, Forget PP, Van Der Meer SB, Wanders RJ, Waterham HR, et al. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature. Acta Paediatr 2003; 92: 501–4. 15 Den Boer ME, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyans JS, et al. Heterozygosity for common LCHAD mutation (1528G>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000; 48: 151–4. 16 Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Hepatology 1994; 19: 339–45. 17 Mak IT, Kramer JH, Weglicki WB. Potentiation of free radical-induced lipid peroxidation injury to the sarcolemmal membranes by lipid amphiphiles. J Biol Chem 1986; 261: 1153–7. 18 Thiele IGI, Niezen-Koning KE, Van Gennip AH, Aarnoudse JG. Increased plasma carnitine concentrations in preeclampsia. Obstet Gynecol 2004; 103: 876–80. Citing Literature Volume114, Issue8August 2007Pages 1028-1030 ReferencesRelatedInformation